Parkinsonian Disorders: Clinical Trials

4,717 trials for Parkinsonian Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2481 completed, 755 unknown, 647 recruiting, 256 terminated. 2077 Not applicable, 645 Phase 2, 443 Phase 1, 298 Phase 3, 186 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2077Completed 986, Unknown 398, Recruiting 328, Not yet recruiting 108, Terminated 93, Active not recruiting 74, Enrolling by invitation 44, Withdrawn 41, Suspended 5
Phase 2645Completed 383, Unknown 71, Terminated 56, Recruiting 54, Withdrawn 27, Active not recruiting 26, Not yet recruiting 22, Enrolling by invitation 4, Suspended 2
Phase 1443Completed 281, Recruiting 47, Unknown 36, Terminated 27, Not yet recruiting 19, Withdrawn 16, Active not recruiting 13, Enrolling by invitation 3, Suspended 1
Phase 3298Completed 216, Terminated 32, Unknown 18, Recruiting 16, Withdrawn 8, Active not recruiting 4, Not yet recruiting 4
Phase 4186Completed 112, Unknown 28, Terminated 17, Recruiting 12, Not yet recruiting 6, Enrolling by invitation 5, Withdrawn 4, Active not recruiting 1, Suspended 1
Early Phase 158Completed 25, Recruiting 12, Unknown 7, Not yet recruiting 5, Terminated 4, Withdrawn 3, Active not recruiting 2

Follow Parkinsonian Disorders: new trials by email Literature Review of Parkinsonian Disorders trials Research Report on Parkinsonian Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Terazosin And Metabolic Energetics in Parkinson's Disease
Terazosin 5 MG, Placebo - Parkinson's Disease (PD)
Phase 2SuspendedErgun Y. Uc1202028-07-012026-10-09
Double-Blind Clinical Trial of Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease
active subthalamic nucleus deep brain stimulation plus optimal drug therapy, inactive subthalamic nucleus deep brain stimulation plus optimal drug therapy - Parkinson Disease
Not applicableNot yet recruitingMallory Hacker402028-01-012026-02-20
Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.
Gemfibrozil, Placebo - Parkinson Disease
Phase 2WithdrawnForest Hills Lab2027-11-012026-08-19
Terazosin for Dementia With Lewy Bodies
Terazosin Hydrochloride, Placebo - Dementia With Lewy Bodies
Phase 1 / Phase 2Not yet recruitingQiang Zhang402027-10-012026-03-12
A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects With Early Parkinson's Disease
MT101-5 - Parkinson's Disease
Phase 2Not yet recruitingMthera Pharma Co., Ltd.1202027-09-012026-10-16
Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD)
rTMS - Parkinson Disease
Not applicableNot yet recruitingUniversity of Michigan202027-09-012026-10-20
Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics
Levodopa (L-dopa) - Parkinson's Disease
Phase 4Not yet recruitingBeth Israel Deaconess Medical Center402027-07-012026-08-28
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
Fecal Microbiota Transplant - Parkinson Disease
Phase 1Not yet recruitingProgenaBiome102027-07-012026-10-09
Engage-PD: a Physical Activity Coaching Program Via Telehealth for People With Parkinson's Disease. A Single-cohort Study in Spain.
Physical Activity Coaching - PARKINSON DISEASE (Disorder)
Not applicableNot yet recruitingHospital Clinic of Barcelona302027-06-012026-10-05
Sustained Release Oral Formulation For Treatment Of Parkinsons Disease
Formulation A, Formulation B, Formulation C - Healthy Volunteers
Phase 1 / Phase 2Not yet recruitingUniversity of Minnesota322027-04-012026-10-01
Expiratory Muscle Training in Parkinson's Disease With Forward Trunk Flexion
Expiratory muscle strength training - Parkinson's Disease
Not applicableNot yet recruitingGeneral University Hospital, Prague282027-02-012026-11-12
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
AB-1005 - Parkinson Disease
Phase 2Not yet recruitingBayer82027-01-252026-07-29
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB)
Not yet recruitingBioSensics602027-01-152026-10-13
Magnetic-Resonance Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson's Disease
MR-guided Focused Ultrasound Pallidothalamic Tractotomy, MR-guided Focused Ultrasound VIM Thalamotomy, Combined MR-guided Focused Ultrasound PTT and VIM Treatment - Parkinson Disease (PD)
Not applicableNot yet recruitingResearch Center of Neurology, Russia1682027-01-152026-11-12
Strength and Dual-Task on Sarcopenia in People With Parkinson's Disease
Nutricional Education and General Exercise Guidelines, Progressive Resistance Training With Cognitive Dual-Task Training, Progressive Resistance Training With Cognitive Dual-Task and Inestability Training - PARKINSON DISEASE (Disorder), Parkinsonism or Parkinson's Disease Nos
Not applicableRecruitingUniversity of Valencia602027-01-112026-10-30
Exploring the Efficacy of the Effortful Swallow Maneuver for Improving Swallowing in People With PD
Effortful swallow - Dysphagia, Parkinson Disease (PD)
Not applicableNot yet recruitingUniversity of Alberta742027-01-012026-08-19
A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)
ONO-2808, Placebo - Multiple System Atrophy, Parkinson Variant
Phase 3Not yet recruitingOno Pharmaceutical Co., Ltd.4862027-01-012026-09-17
Probing Gut-Brain Communication in Parkinson's Disease
taVNS, Sham taVNS - Parkinson Disease (PD)
Not applicableNot yet recruitingSpaulding Rehabilitation Hospital452027-01-012026-10-08
Estimates of the Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease
Talineuren, Placebo - Parkinson Disease
Phase 2Not yet recruitingInnoMedica Schweiz AG402027-01-012026-10-30
Expiratory Muscle Training and Trunk Flexion in Parkinson's Disease
Expiratory muscle strength training - Parkinson Disease
Not applicableNot yet recruitingGeneral University Hospital, Prague302027-01-012026-11-12

Showing 20 of 4717. Sign in to see all of them.

Narrower conditions

Parkinson Disease (4499)  ·  Lewy Body Disease (237)  ·  Alzheimer Disease (210)  ·  Cognitive Dysfunction (164)  ·  Movement Disorders (163)  ·  Motor Activity (162)  ·  Dementia (146)  ·  Neurodegenerative Diseases (122)  ·  Dyskinesias (110)  ·  Multiple System Atrophy (104)  ·  Multiple Sclerosis (100)  ·  Depression (97)  ·  Essential Tremor (97)  ·  Stroke (88)

Broader conditions

Basal Ganglia Diseases (4685)  ·  Central Nervous System Diseases (4672)  ·  Brain Diseases (4669)  ·  Nervous System Diseases (4642)  ·  Synucleinopathies (4641)  ·  Neurodegenerative Diseases (4555)  ·  Movement Disorders (4554)  ·  Pathological Conditions, Signs and Symptoms (886)  ·  Signs and Symptoms (742)  ·  Mental Disorders (712)  ·  Neurologic Manifestations (606)  ·  Neurocognitive Disorders (490)  ·  Behavior (323)  ·  Tauopathies (257)

Interventions

Levodopa (89)  ·  Deep Brain Stimulation (81)  ·  Exercise (79)  ·  carbidopa, levodopa drug combination (74)  ·  Transcranial Direct Current Stimulation (52)  ·  Transcranial Magnetic Stimulation (46)  ·  rasagiline (45)  ·  Pramipexole (44)  ·  opicapone (43)  ·  rotigotine (43)  ·  Physical Therapy Modalities (37)  ·  Carbidopa (34)  ·  Control Groups (29)  ·  Apomorphine (26)  ·  entacapone (23)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (64)  ·  Bial - Portela C S.A. (56)  ·  Boehringer Ingelheim (42)  ·  University of Florida (42)  ·  VA Office of Research and Development (42)  ·  Oregon Health and Science University (36)  ·  Radboud University Medical Center (35)  ·  University Hospital, Toulouse (34)  ·  University of Minnesota (34)  ·  University of Colorado, Denver (33)  ·  Washington University School of Medicine (32)  ·  AbbVie (30)  ·  University Hospital, Grenoble (27)  ·  National Taiwan University Hospital (26)  ·  Assistance Publique - Hôpitaux de Paris (25)

Countries

United States (1706)  ·  France (445)  ·  Italy (352)  ·  China (289)  ·  Germany (261)  ·  Canada (253)  ·  United Kingdom (250)  ·  Spain (224)  ·  Turkey (Türkiye) (171)  ·  Israel (122)  ·  Netherlands (121)  ·  Taiwan (120)  ·  Brazil (104)  ·  Switzerland (83)  ·  Austria (82)

Top investigators

Giuseppe Frazzitta, MD (16)  ·  Danna Jennings, MD (11)  ·  Alice Nieuwboer, PhD (8)  ·  Bastiaan R Bloem, MD, PhD (7)

Results publications

PMID 36602886, PMID 38588457, PMID 40680102, PMID 31356217, PMID 25623333, PMID 30741694, PMID 31127735, PMID 10816186, PMID 19025984, PMID 19126811, PMID 34816053, PMID 41626017, PMID 11253156, PMID 12112073, PMID 12360555, PMID 12498954, PMID 1454205, PMID 15097290, PMID 16267188, PMID 16401616, PMID 16436781, PMID 17941858, PMID 19058133, PMID 20457959, PMID 20519680, PMID 20574039, PMID 20582993, PMID 20841416, PMID 20937936, PMID 20946640, PMID 21484867, PMID 21542016, PMID 22209649, PMID 22750016, PMID 22850494, PMID 23263599, PMID 23667214, PMID 23860343, PMID 24078735, PMID 24251381, PMID 24332532, PMID 24412048, PMID 24711047, PMID 25185211, PMID 26347184, PMID 26523919, PMID 26833853, PMID 26882318, PMID 27085534, PMID 27153166

NIH funding

2019 (14), 2016 (13), 2023 (12), 2025 (11), 2009 (10), 2017 (10), 2018 (10), 2008 (9), 2014 (9), 2004 (7), 2015 (7), 2005 (4), U01NS043128 (3), I01RX003397 (2), K23NS080912 (2)